- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT03044119
The Effect of Platelet Rich Fibrin Matrix With and Without Peripheral Blood Mesenchymal Stem Cells on Implant Stability
A Comparative Evaluation of the Effect of Platelet Rich Fibrin Matrix With and Without Peripheral Blood Mesenchymal Stem Cells on Implant Stability : A Randomized Controlled Clinical Trial
The Primary Objectives of the present study are :
- To Evaluate the effect of platelet rich fibrin matrix (PRFM) and peripheral blood mesenchymal stem cells (PBMSCs) on implant stability.
- To Compare the effect of platelet rich fibrin matrix (PRFM) alone to peripheral blood mesenchymal stem cells (PBMSCs) embedded in platelet rich fibrin matrix (PRFM) on implant stability.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
The addition of molecules or growth factors to the implant surface is an approach to enhance bone to implant contact (BIC).1 Platelet rich fibrin matrix (PRFM) is an autologous concentrated platelet-rich thrombin free fibrin matrix, prepared by two step centrifugation of blood. Platelets isolated, remain intact and retain their growth factor compliment. This allows a more effective, sustained release of growth factors to the wound site following PRFM application.2 During the second spin, a cross-linking of fibrin takes place, resulting in the formation of a dense fibrin matrix, within which a concentration of viable platelets can be found. Having an organized fibrin matrix at the start of healing accelerates the speed of vascular ingress into the wound compared to non-accelerated healing, which requires a longer time for fibrin formation and the development of vascularity. The earlier the vascularity is established, faster is the migration of the bone-forming cells at the wound site and initiation of bone formation. Therapeutic applications of platelet-rich products have led to improved bone regeneration and faster titanium implant osseointegration, which improve the stability and maintenance of dental implants by increasing BIC.1 Mesenchymal stem cells (MSCs) is a multipotent stromal cell with prominent regenerative functions. MSCs were first identified and isolated from bone marrow and then found in various tissues including umbilical cord, adipose tissue and peripheral blood. Among these sources peripheral blood MSCs draw increasing attention as they share similar biological characteristics with MSCs derived from bone marrow or adipose tissue. Bone marrow derived mesenchymal stem cells(BMMSCs) are multipotent cells capable of differentiating into osteoblasts, chondrocytes, adipocytes , fibroblasts, tenocytes, and myoblasts , which are considered as a cell source for various tissue repair and regenerating bone defects.3 The requirements of aspiration of bone marrow from the patient will cause pain and morbidity of the donor sites. It will be very convenient if peripheral blood mesenchymal stem cells (PBMSCs) could be harvested and expanded to enough numbers, with their osteogenic capacity maintained in a clinical permitted period.
The literature search does not show any human clinical trial conducted till date to assess the regenerative potential of this new modality i.e. PRFM and peripheral blood mesenchymal stem cells. This study therefore aims at the evaluation of PRFM and PBMSCs as regenerative materials for implant stability.
Studietyp
Inskrivning (Förväntat)
Fas
- Fas 1
Kontakter och platser
Studieorter
-
-
Karnataka
-
Bengaluru, Karnataka, Indien, 560022
- Rekrytering
- Kle Society'S Institute of Dental Sciences
-
Kontakt:
- laveena singhal, mds
- Telefonnummer: 9900330579
- E-post: laveenasinghal13@gmail.com
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Patient with age group between 25-50 years
- Radiographic imaging(IOPA/OPG/CBCT/RVG) of the area of interest showing sufficient residual bone volume to receive two or more adjacent implants of ≥ 3.5 mm in diameter and 11.0 mm in length
- Extraction at least 6 months prior to the study.
Exclusion Criteria:
- Para-functional habits
- Smoking more than 10 cigarettes per day
- Excessive consumption of alcohol
- Patient's with systemic diseases contraindicated for surgery
- Localized radiotherapy, Antitumor chemotherapy of the oral cavity
- Liver, blood, and/or kidney diseases
- Immunosuppression
- Current corticosteroid or bisphosphonate use;
- Pregnancy
- Mucocutaneous diseases involving the oral cavity and
- Poor oral hygiene.
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Trippel
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
---|---|
Aktiv komparator: Dental Implant with PRFM
Intervention in the form of Dental Implants placement in the adjacent edentulous bone with the placement of platelet rich fibrin matrix a biological material procured from patient's peripheral blood
|
placement of a minimum of two adjacent dental implants being randomly assigned into (G1) - Dental implant with PRFM
|
Experimentell: Dental Implant with PRFM and PBMSCs
Intervention in the form of Dental Implant placement in the adjacent edentulous bone with the placement of platelet rich fibrin matrix and peripheral blood mesenchymal stem cells which are the biological materials procured from patient's peripheral blood
|
placement of a minimum of two adjacent dental implants being randomly assigned into (G2) - Dental implant with peripheral blood mesenchymal stem cells embedded in PRFM.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Insertion torque values at the time of placement of dental implant
Tidsram: on the implant placement day
|
insertion torque values will be recorded during the day of placement of implants.
|
on the implant placement day
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Implant stability quotient (ISQ) using Resonance frequency analysis (RFA).
Tidsram: 3 months
|
Implant stability quotient (ISQ) using Resonance frequency analysis (RFA) with the help of Osstell device at 1 week, 1 month and 3 months post operatively
|
3 months
|
Samarbetspartners och utredare
Utredare
- Huvudutredare: Sudhir R Patil, MDS, Kle Society'S Institute of Dental Sciences
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Förväntat)
Avslutad studie (Förväntat)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Andra studie-ID-nummer
- KLESInstitute
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
IPD-planbeskrivning
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Tandimplantat
-
Cairo UniversityOkändPEEK Implant Supported Restoration
-
ASST Santi Paolo e CarloAvslutadTandimplantat | Marginal benförlust | Peri Implant Health | Supral vävnadshöjdItalien
-
Mayo ClinicAnmälan via inbjudanOrtopedisk störning | Retained Metal ImplantFörenta staterna
-
Federal University of PelotasOkändDental restaurering misslyckande | Estetik, Dental | Dentala restaureringar Lång livslängdBrasilien
-
Minia UniversityAvslutad
-
Ain Shams UniversityRekrytering
-
University of JordanUpphängdDental restaureringJordanien
-
University of Nove de JulhoAvslutad
-
Kıvanç AkçaHacettepe UniversityAvslutad
Kliniska prövningar på Dental Implant with PRFM
-
Clark StanfordIndragen
-
Implantology InstituteOkändBenförlust | ImplantatPortugal